NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 44 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $102,000 | -89.3% | 259,441 | -71.4% | 0.03% | -91.1% |
| Q2 2022 | $952,000 | -44.1% | 906,445 | 0.0% | 0.36% | -36.5% |
| Q1 2022 | $1,704,000 | -33.1% | 906,445 | 0.0% | 0.56% | -26.6% |
| Q4 2021 | $2,547,000 | -22.2% | 906,445 | 0.0% | 0.77% | -26.4% |
| Q3 2021 | $3,272,000 | -21.4% | 906,445 | +4.3% | 1.04% | +0.9% |
| Q2 2021 | $4,161,000 | +43.0% | 868,699 | +120.7% | 1.03% | +75.3% |
| Q1 2021 | $2,909,000 | +41.7% | 393,699 | +34.0% | 0.59% | +40.5% |
| Q4 2020 | $2,053,000 | -11.1% | 293,699 | -3.5% | 0.42% | -8.1% |
| Q3 2020 | $2,310,000 | +46.7% | 304,376 | +69.7% | 0.46% | -0.7% |
| Q2 2020 | $1,575,000 | – | 179,404 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |